Pharmacology, Toxicology and Pharmaceutical Science
Cardiovascular Disease
33%
Conjugated Estrogen
66%
Ethinylestradiol
66%
Glutaryl-CoA
100%
High Density Lipoprotein Cholesterol
66%
Liver Protein
33%
Low Density Lipoprotein Cholesterol
100%
Low Density Lipoprotein Receptor
100%
Menopausal Syndrome
33%
Oxidoreductase
66%
Prevalence
33%
Rat Model
100%
Sprague Dawley Rat
33%
Triacylglycerol
66%
Western Blot
66%
Keyphrases
3-hydroxy-3-methylglutaryl-CoA Reductase
25%
3-hydroxy-3-methylglutaryl-coenzyme A
12%
Cardiovascular Risk
12%
Chinese Medicinals
100%
Cholesterol
37%
Deprivation
12%
Erxian Decoction
100%
Estrogen
12%
Estrogen Biosynthesis
12%
Hepatic Proteins
12%
High-density Lipoprotein Cholesterol (HDL-C)
12%
Low-density Lipoprotein Cholesterol (LDL-C)
37%
Low-density Lipoprotein Receptor
37%
Menopausal Syndrome
12%
Menopause
100%
Premarin
25%
Protein Level
25%
Rat Model
100%
Serum Levels
50%
Serum Lipids
100%
Sprague-Dawley Rats
12%
Triglyceride to High-density Lipoprotein Cholesterol Ratio
12%
Triglycerides
12%
Western Blot
25%
Young Female
12%
Medicine and Dentistry
Cardiovascular Disease
12%
Decoction
100%
Downregulation
12%
Estrogen Synthesis
12%
Ethinylestradiol
25%
Glutaryl-CoA
37%
High Density Lipoprotein Cholesterol
25%
LDL Receptor
37%
Liver Protein
12%
Low Density Lipoprotein Cholesterol
37%
Menopausal Syndrome
12%
Oxidoreductase
25%
Prevalence
12%
Triacylglycerol
25%
Upregulation
12%
Western Blot
25%